1. Home
  2. CURR vs DERM Comparison

CURR vs DERM Comparison

Compare CURR & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Currenc Group Inc. Ordinary Shares

CURR

Currenc Group Inc. Ordinary Shares

SELL

Current Price

$1.88

Market Cap

208.8M

ML Signal

SELL

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

HOLD

Current Price

$3.33

Market Cap

190.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CURR
DERM
Founded
2013
2014
Country
Singapore
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.8M
190.3M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CURR
DERM
Price
$1.88
$3.33
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $12.75
AVG Volume (30 Days)
★ 243.0K
198.6K
Earning Date
12-01-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 34.72
EPS
★ N/A
N/A
Revenue
$46,435,412.00
★ $61,858,000.00
Revenue This Year
$12.39
$18.51
Revenue Next Year
N/A
$39.47
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 10.20
52 Week Low
$1.31
$3.40
52 Week High
$5.08
$9.56

Technical Indicators

Market Signals
Indicator
CURR
DERM
Relative Strength Index (RSI) 36.11 25.69
Support Level $1.43 N/A
Resistance Level $3.50 $5.49
Average True Range (ATR) 0.23 0.34
MACD 0.03 -0.07
Stochastic Oscillator 64.18 2.84

Price Performance

Historical Comparison
CURR
DERM

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It operates into two reportable segments, which are remittance services and sales of airtime, of which maximum revenue is generated from the Remittance segment. Geographically, the group generates the majority of its geographic revenue from Malaysia.

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Share on Social Networks: